Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

PHASE3CompletedINTERVENTIONAL

Enrollment

547

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Rhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Interventions

DRUG

5-mg Desloratadine

5-mg Desloratadine tablet, once daily for 15 days

DRUG

Placebo

Placebo tablet, once daily for 15 days

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00406783 - Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) | Biotech Hunter | Biotech Hunter